SYNACTHEN 0.25 mg/ml i.m./i.v. amp 1 ml
7680317230012
CH-31723
H01AA02
07.07.1.
1 / 3
google
Details
- Product number
- 3172301
- CPT
- -
- Packaging group
- 1 x 1 ml
- Unit
- Ampulle(n)
- Composition
- tetracosactidum 0.25 mg ut tetracosactidi hexaacetas, acidum aceticum glaciale, natrii acetas trihydricus, natrii chloridum, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium 3.34 mg.
Articles (1)
Synacthen, Injektionslösung
Injektionslösung
1 x 1 ml
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
0.25 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
3.34 MG | Substance | HBESI |
Authorization holder
Curatis AG
4410 Liestal
Authorization information
- Swissmedic authorization number
- 31723
- Drug name
- Synacthen, Injektionslösung
- Galenic form
- LSIN
- ATC Code
- H01AA02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 18/11/1965
- Authorization expiration date
- 31/12/9999
- IT number
- 07.07.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SYNACTHEN 0.25 mg/ml i.m./i.v. amp 1 ml
- Description (DE)
- SYNACTHEN 0.25 mg/ml i.m./i.v. Amp 1 ml
- Market launch
- 18/11/1965
- Narcotic (BTM)
- No